Wang Yingjie, Zhou Di, Bai Xiaolin, Meng Qingqi, Xie Haihui, Wu Guojiang, Chen Gang, Hou Yue, Li Ning
School of Traditional Chinese Materia Medica, Key Laboratory of Innovative Traditional Chinese Medicine for Major Chronic Diseases of Liaoning Province, Key Laboratory for TCM Material Basis Study and Innovative Drug Development of Shenyang City, Shenyang Pharmaceutical University, Shenyang 110016, China.
Tasly Northeast Modern TCM Resources Co., Ltd., Benxi 117204, China.
Chin Herb Med. 2023 Feb 20;15(3):463-469. doi: 10.1016/j.chmed.2022.08.010. eCollection 2023 Jul.
To investigate the chemical constituents from the leaves of and evaluate their inhibition on lipopolysaccharide (LPS)-activated BV-2 microglia cells.
The -BuOH extract of the leaves of was isolated by macroporous adsorption resin, silica gel, ODS, column chromatography and semi-preparative HPLC. The structures of the compounds were identified by MS, NMR, ECD, and other spectroscopic methods. In addition, anti-neuroinflammatory effects of isolated compounds were evaluated by measuring the production of nitric oxide (NO) in over-activated BV-2 cells.
Seventeen compounds, including (7,8)-crataegifin A-4----glucopyranoside (), (8,8')-arctigenin (), arctigenin-4'----glucopyranoside (), (-)-syringaresinol (), syringaresinol-4'----glucopyranoside (), (-)-pinoresinol (), pinoresinol-4'----glucopyranoside (), buddlenol D (), (2,3)-dihydroquercetin (), (2,3)-epicatechin (), (2,3)-catechin (), isovitexin (), naringenin-7----glucopyranoside (), chamaejasmin (), neochamaejasmin B (), isoneochamaejasmin A (), and tomentin-5----glucopyranoside () were isolated and identified. Compounds , and significantly inhibited the release of NO in BV-2 microglia activated by LPS, with IC values of 18.34, 29.33 and 26.30 μmol/L, respectively.
Compound is a novel compound, and compounds , , , - are isolated from genus for the first time. In addition, the lignans significantly inhibited NO release and the inhibitory activity was decreased after glycosylation.
研究[植物名称未给出]叶的化学成分,并评估其对脂多糖(LPS)激活的BV-2小胶质细胞的抑制作用。
采用大孔吸附树脂、硅胶、ODS柱色谱和半制备HPLC对[植物名称未给出]叶的正丁醇提取物进行分离。通过质谱、核磁共振、电子圆二色谱和其他光谱方法鉴定化合物的结构。此外,通过测量过度激活的BV-2细胞中一氧化氮(NO)的产生来评估分离化合物的抗神经炎症作用。
分离并鉴定了17种化合物,包括(7,8)-山楂叶皂苷A-4----葡萄糖苷([化合物名称未完整给出])、(8,8')-牛蒡子苷元([化合物名称未完整给出])、牛蒡子苷元-4'----葡萄糖苷([化合物名称未完整给出])、(-)-丁香树脂醇([化合物名称未完整给出])、丁香树脂醇-4'----葡萄糖苷([化合物名称未完整给出])、(-)-松脂醇([化合物名称未完整给出])、松脂醇-4'----葡萄糖苷([化合物名称未完整给出])、醉鱼草醇D([化合物名称未完整给出])、(2,3)-二氢槲皮素([化合物名称未完整给出])、(2,3)-表儿茶素([化合物名称未完整给出])、(2,3)-儿茶素([化合物名称未完整给出])、异荭草素([化合物名称未完整给出])、柚皮素-7----葡萄糖苷([化合物名称未完整给出])、白花败酱醇([化合物名称未完整给出])、新白花败酱醇B([化合物名称未完整给出])、异新白花败酱醇A([化合物名称未完整给出])和托门亭-5----葡萄糖苷([化合物名称未完整给出])。化合物[未明确指出的几个化合物]、[未明确指出的几个化合物]和[未明确指出的几个化合物]显著抑制LPS激活的BV-2小胶质细胞中NO的释放,IC50值分别为18.34、29.33和26.30 μmol/L。
化合物[未明确指出的化合物]是一种新化合物,化合物[未明确指出的几个化合物]、[未明确指出的几个化合物]、[未明确指出的几个化合物]、[未明确指出的几个化合物]首次从[植物属名未给出]属中分离得到。此外,木脂素显著抑制NO释放,糖基化后抑制活性降低。